DrugPatentWatch Database Preview
Profile for China Patent: 101060874
» See Plans and Pricing
US Patent Family Members and Approved Drugs for China Patent: 101060874
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Aug 3, 2026 | Novo | OZEMPIC | semaglutide |
Start Trial | Feb 3, 2027 | Novo | SAXENDA | liraglutide recombinant |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |